iving your chemotherapy. The On-body Injector for Neulasta is programmed to deliver your dose about 27 hours after your healthcare provider places the On-body Injector for Neulasta on your skin.
Do not expose the On-body Injector for Neulasta to the following because the On-body Injector for Neulasta may be damaged and you could be injured:
• MRI
• X-ray
• CT-Scan
• Ultrasound
• Oxygen rich environments, such as hyperbaric chambers
Avoid airport X-ray scans. Request a manual pat down instead. Use care during a manual pat down to help prevent the On-body Injector for Neulasta from being accidentally removed.
Keep the On-body Injector for Neulasta at least 4 inches away from electrical equipment such as cell phones, cordless telephones, microwaves and other common appliances. If the On-body Injector for Neulasta is too close to electrical equipment, it may not work correctly and can lead to a missed or incomplete dose of Neulasta.
The On-body Injector is for adult patients only.
Call your healthcare provider right away if the:
• On-body Injector for Neulasta comes off before or during a dose delivery.
Do not re-apply it.
• On-body Injector for Neulasta is leaking.
• adhesive on your On-body Injector for Neulasta becomes noticeably wet (saturated) with fluid, or there is dripping. This may mean that Neulasta is leaking out of your On-body Injector for Neulasta. If this happens you may only receive some of your dose of Neulasta, or you may not receive a dose at all.
• On-body Injector for Neulasta status light is flashing red.
What is Neulasta?
Neulasta is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low blood cell count.
Who should not take Neulasta?
Do not take Neulasta if you have had a serious allergic reaction to pegfilgrastim (Neulasta®) or to filgrastim (Neupogen®).
What should I tell my healthcare provider before receiving Neulasta?
Before you receive Neulasta, tell your healthcare provider if you:
have sickle cell trait or sickle cell disease
have had severe skin reactions to acrylic adhesives
are allergic to latex
have problems with your kidneys
have any other medical problems
are pregnant or plan to become pregnant. It is not known if Neulasta may harm your unborn baby.
Pregnancy Registry: There is a pregnancy registry for women who become pregnant during treatment with Neulasta. The purpose of this registry is to collect information about the health of you and your baby. You are encouraged to enroll in this registry. Your healthcare provider may enroll you, or you may enroll by calling 1-800-AMGEN (1-800-772-6436).
are breastfeeding or plan to breastfeed. It is not known if Neulasta passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How will I receive Neulasta?
See the Instru